Endometriosis is one of the most stubborn conditions in women’s health. Around one in ten women of reproductive age live with it, and for many it means years of pain, heavy periods, fatigue, and sometimes infertility. Current treatments aren’t ideal. Hormone suppression often brings unpleasant side effects, and surgery carries risks of recurrence — up to 40% of women need repeat operations within five years. Vesicle-Based Corridor Therapies for Endometriosis I’ve just published a new paper that proposes a different way forward: vesicle-based corridor therapies . This sounds technical, so let’s unpack it. What makes endometriosis so hard to treat? Endometrial tissue belongs in the uterus, where it follows a precise monthly cycle. But in endometriosis, those same cells appear outside — on ovaries, bowel, bladder, or peritoneum. Instead of behaving, they build tiny “corridors” that don’t match the tissue around them. Think of it as electrical wiring crossed at the wrong angle. The resu...